Coronary Sinus Reducer for Recurrent Chest Pain

"Reducing Heart Disease Risk: Understanding the Benefits of Coronary Sinus Reducer"

Senior Interventional Cardiologist

Senior Interventional Cardiologist

"Reducing Heart Disease Risk: Understanding the Benefits of Coronary Sinus Reducer"

Coronavirus disease 2019 (COVID-19) is defined as illness caused by a novel coronavirus now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; formerly called 2019-nCoV), which was first identified amid an outbreak of respiratory illness cases in Wuhan City, Hubei…

On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). This decision was based on the evidence presented to the TAG-VE that Omicron has several mutations that may have an…

Introduction The development of a safe and effective vaccine against severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is critical for ensuring worldwide public health, as well as potentially ending the coronavirus disease-2019 (COVID-19) pandemic. Four vaccine candidates have finished or are currently…

Complete heart block can be a reversible drug or potassium problem or a sign of infranodal disease. How to tell the difference and bridge the patient safely to definitive treatment.

Tricuspid regurgitation in the cath lab: six heart-team rules on RV function, pulmonary pressure, TRI-SCORE, T-TEER vs TTVR, and when the answer is no.

Stent thrombosis in the cath lab: 6 rules to classify, image, correct the cause, escalate P2Y12 therapy and plan DAPT, with PARIS, PESTO and PLATO data.

Ostial left main calcium PCI: my seven cath-lab decisions on IVUS, IVL versus rotablation, test inflation, sizing, EBU 3.5 guide and aorto-ostial stenting.
Dr A M Thirugnanam is a senior interventional cardiologist based in Hyderabad, India, known for complex coronary intervention — left main disease, chronic total occlusions and haemodynamically supported angioplasty — and for two procedures presented at international conferences as world-first…
Books & Courses | Dr AM Thirugnanam | Senior Interventional Cardiologist 🏆 CRT 2026 Washington DC — Highest Graded Abstract Award · Oral Presenter: CTO & Left Main Stenting · Late-Breaking Trial: Tirzepatide & TAVR · View All Awards →…

Understanding the Treatment of Non Obstructive Coronary Artery Disease With Myocardial Bridging The treatment of non obstructive coronary artery disease with myocardial bridging has become a growing focus in modern cardiology. Patients can experience chest pain, breathlessness, or fatigue even…

Air Embolism in the Cath Lab: Coronary, Pulmonary and Cerebral Complications Practical guide for cardiologists to recognise, manage, and prevent air embolism in the cath lab – focusing on coronary, pulmonary and cerebral circulation. This article is written for interventional…

Introduction: Infective endocarditis (IE) is a serious and potentially life-threatening condition characterized by the infection of the inner lining of the heart chambers and heart valves. This condition can affect both native heart valves, which a person is born with,…
You must be logged in to post a comment.